| Catalog | name | Description | price |
|---|---|---|---|
| R-R-2793 | [DPro5] Corticotropin Releasing Factor, human, rat TFA | [DPro5] Corticotropin Releasing Factor, human, rat TFA is a selective corticotropin releasing factor/hormone R2 (CRH-R2)agonist. [DPro5] Corticotropin Releasing Factor, human, rat TFA fails to cause the typical anxiogenic effect, but modulates learning and memory processes in rat. | price> |
| R-R-2794 | Stressin I TFA | Stressin I (Cyclo(31-34)[DPhe12,Nle21,38,Glu31,Lys34]Ac-hCRF(4-41)) TFA is a potent CRF1 receptor selective agonist, Ki is 1.7 nM. Stressin I induces an increase in adrenocorticotropic hormone (ACTH) levels in rats. | price> |
| R-R-2795 | Pexacerfont CAS No.459856-18-9 | Pexacerfont/CAS No.459856-18-9 is a selective corticotropin-releasing factor (CRF1) receptor antagonist with IC50 of 6.1±0.6 nM for human CRF1 receptor. | price> |
| R-R-2796 | Antisauvagine-30 TFA | Antisauvagine-30 TFA (aSvg-30 TFA) is a potent, highly selective and competitive CRF2 receptor peptidic antagonist. Antisauvagine-30 TFA exhibits a Kd of 1.4 nM and 150 nM for mCRFR2β and CRFR1, respectively. | price> |
| R-R-2797 | Urocortin III, mouse TFA | Urocortin III, mouse TFA is a corticotropin-releasing factor (CRF)-related peptide. Urocortin III preferentially binds and activates CRF-R2. Urocortin III (Ucn3) is a known component of the behavioral stress response system. Urocortin III and CRF-R2 in the medial amygdala regulate complex social dynamics. | price> |
| R-R-2798 | CP 376395 CAS No.175140-00-8 | CP 376395/CAS No.175140-00-8 is a potent, selective, and brain-penetrable Corticotropin releasing factor 1 (CRF1) receptor antagonist. | price> |
| R-R-2799 | DMP 696 CAS No.202578-52-7 | DMP 696/CAS No.202578-52-7 is a selective corticotropin-releasing hormone receptor 1 (CRHR1) antagonist, used for the treatment of anxiety and depression. | price> |
| R-C-1100 | Macitentan CAS:441798-33-0 | Macitentan is an orally active,non-peptide dual endothelin ETA and ETB receptor antagonist for the potential treatment of idiopathic pulmonary fibrosis(IPF)and pulmonary arterial hypertension(PAH). | price> |
| R-R-2800 | Tildacerfont CAS No.1014983-00-6 | Tildacerfont/CAS No.1014983-00-6 is a potent and orally active corticotrophin-releasing factor type 1 (CRF1) receptort antagonis. Tildacerfont effectively reduces adrenocorticotropic hormone (ACTH) and adrenal androgen levels. Tildacerfont has favourable safety profile. Tildacerfont can be used for researching congenital adrenal hyperplasia. | price> |
| R-R-2801 | Antalarmin CAS No.157284-96-3 | Antalarmin/CAS No.157284-96-3 is a selective nonpeptide corticotropin-releasing factor receptor 1 (CRHR1) antagonist with a Ki of 2.7 nM. Antalarmin can pass through the blood–brain barrier. | price> |

Items-$0.00

Email:
Tel.:
RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China
Tel: 02988811435
Fax: (86-29)8881-1435
Email: sales@ruixibiotech.com
Web: http://www.ruixibiotech.com


